This World #AMR Awareness Week, IVI echoes the call to “Act Now: Protect Our Present, Secure Our Future.” Vaccines reduce infections and antimicrobial use, helping slow AMR. See how we integrate AMR across research, surveillance, and vaccine delivery ⤵️ https://t.co/tWgUE4eTWV

We are grateful to all who joined the IVI-@Uni_Rwanda Joint Symposium in Kigali, where researchers, clinicians, and the IVI Board came together—driving progress on innovation, vaccine science, and sustainable health systems across Africa.

IVI’s Board of Trustees met in Kigali this week for a reflective and forward-looking discussion on strengthening vaccine science and innovation across Africa. Grateful to our partners in Rwanda for their collaboration and hospitality. 🔗 Learn more: https://t.co/llFQXqZ5ZQ

IVI and @NVITH_Official have renewed our long-standing partnership, strengthening vaccine R&D, international collaboration, and regional capacity building. Together, we’ll continue driving progress toward stronger vaccine equity and preparedness across ASEAN and beyond.

What will it take to achieve #VaccineEquity? In the latest episode of The #HealthEquity podcast, @JayasreeKIyer speaks with @drjeromekim1, Director General of @IVIHeadquarters about building #vaccine security & ensuring access for all. Listen here➡️ https://t.co/3YEmzUplnY

The Kenya Bio-Vaccine Mission Program in the Republic of Korea (23rd–30th October 2025) brought together Kenyan experts and institutions, including @BioVaxInstitute, to benchmark @KOREA's world-class vaccine research, manufacturing, and innovation ecosystem. Through visits to

On Nov 10, @hkjcghi & @IVIHeadquarters hosted a symposium in Bangkok on pandemic preparedness—sharing lessons from COVID-19 and strategies for rapid research during emergencies. Key message: “No country is safe until all countries are safe.” #GlobalHealth #PandemicPreparedness

Vaccine equity happens when global collaboration meets local empowerment. @drjeromekim1 joins @AtMIndex The Health Equity podcast to discuss advancing vaccine security and incentivizing innovation for low- and middle-income countries. 🎧 https://t.co/jgWmLuc605

On Thursday, October 30, 2025, in a strategic move to strengthen collaboration in vaccine research and development across Africa, @aphrc and the @IVIHeadquarters signed a Memorandum of Understanding (MoU) at the APHRC Campus in Nairobi. This partnership establishes a

Welcomed leaders from Hilleman Labs—jointly funded by Merck (MSD) and Wellcome—to explore #Collaboration on affordable #Vaccines for LMIC with KDCA, RIGHT Foundation & Adjuvant Capital. Insightful presentations + dialogue on funding gaps = powerful momentum for #GlobalHealth.

IVI, @CEPIvaccines, and Novo Nordisk Foundation Initiative for Vaccines and Immunity will host a conference 2–3 Dec in Stockholm to strengthen Nordic pandemic preparedness, promote vaccine equity, and advance CEPI’s #100DaysMission. 👉 Express interest: https://t.co/qMVOD7pPQi

IVI and @bloompubhealth are joining forces to advance vaccine equity and strengthen health security in Africa. The partnership combines IVI’s scientific expertise with Bloom’s on-the-ground knowledge to build a resilient vaccine ecosystem. 🔗Read more: https://t.co/Dxle4SbWCZ

🧬 Prof. Nicaise Ndembi, Regional Director for IVI, spoke at the Genomic Frontiers: RWANDA 2025 Symposium, highlighting how data and AI-driven predictive models can help forecast pandemics, strengthen preparedness, and guide timely health responses. 💡🌍 Rwanda continues to set

A warm welcome to Ambassador Patricio Esteban Troya Suárez and Mr. Orlin Manuel Madrid Cepeda from @EmbajadaEcuKOR to @IVIHeadquarters. We look forward to expanding Ecuador-IVI collaboration to strengthen regional capacity and drive innovation in vaccine R&D. 🇪🇨

Strengthening the global vaccine workforce for a healthier future. IVI kicks off the Introductory Course for Standard Practice in Seoul under @WHO @mohwpr Global Training Hub for Biomanufacturing, uniting together 210+ participants from 39 countries. 👉 https://t.co/csfkHOG7G4

🥋 Teamwork and taekwondo! IVI hosted a special class with Goodwill Ambassador Hyerim Woo, Taekwondo Master Mincheol Shin, and their son Siwoo—connecting the power of vaccines with the spirit of this martial art. 🎥 Watch the video in our latest blog:

Bold ideas and innovations are shaping the future of vaccines—protecting health at every stage of life. At #WorldVaccineCongress Europe, @drjeromekim1 moderated a panel of global experts on technologies driving progress toward sustainable and inclusive immunization for all.

IVI is honored to receive the 🏆Award of Excellence from @aefutha for the ARC-WA project, funded by @cepivaccines and led with @mrcunitgambia Together, we’re strengthening clinical trial infrastructure and building resilient health networks in West Africa. https://t.co/M3OLwaDf5f

A major step for global health innovation! The Hong Kong Jockey Club Global Health Institute, a partnership between @HKUniversity, @Cambridge_Uni, and @IVIHeadquarters, was officially inaugurated with a plaque-unveiling ceremony at @hkumed 🔗 https://t.co/yb2TAVIOlj

Africa is poised to lead in vaccines, from innovation to production. A new IVI-led study maps the continent’s vaccine ecosystem—R&D funding, clinical trials, regulatory readiness, and manufacturing capacity—and highlights paths toward self-reliance and health security.